Given that rapidly proliferating cancer cells, which naturally produce oncogenic MYC, accumulate more genomic instability, it is logical to assume that late-stage or recurrent cancer cells, which are expected to carry high levels of MYC, must have accumulated more DNA damage. This evidence concerns the gene MYC and cancer.